• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强磁共振成像 T1 mapping 在非酒精性脂肪性肝病评估中的作用。

Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.

机构信息

Department of Radiology, Zhongshan/Hospital of Fudan University, No 180/Fenglin Road, Xuhui District, Shanghai, China, 200032,

出版信息

Eur Radiol. 2014 Apr;24(4):959-66. doi: 10.1007/s00330-014-3096-y. Epub 2014 Jan 26.

DOI:10.1007/s00330-014-3096-y
PMID:24463697
Abstract

OBJECTIVES

This study evaluates the value of Gd-EOB-DTPA-enhanced MRI for diagnosis and staging of non-alcoholic fatty liver disease (NAFLD) in an animal model by T1 relaxation time measurement.

METHODS

Thirty-four rabbits were divided into the control group (n = 10) and NAFLD group, which was split into four groups (n = 6) with a high-fat diet for an interval of 3 weeks. A dual flip angle was performed before and at the hepatobiliary phase (HBP). T1 relaxation times of the liver parenchyma and the decrease rate (∆%) were calculated. Histological findings according to semi-quantitative scoring of steatosis, activity and fibrosis were the standard of reference.

RESULTS

HBP and ∆% T1 relaxation time measurement showed significant differences between normal and NAFLD groups, between non-alcoholic steatohepatitis (NASH) and NAFLD without NASH (p = 0.000-0.049), between fibrosis groups (p = 0.000-0.019), but no difference between F1 and F2 (p = 0.834). The areas under the receiver operating characteristic curves (AUCs) of T1 relaxation time for HBP and ∆% were 0.86-0.93 for the selection of NASH and activity score ≥2, and 0.86-0.95 for the selection of F ≥ 1, 2, 3. No significant difference was found for diagnostic performance between HBP and ∆% T1 relaxation time.

CONCLUSIONS

HBP T1 relaxation time measurement of Gd-EOB-DTPA-enhanced MRI was useful to evaluate NAFLD according to the SAF score. HBP T1 relaxation time measurement was as accurate as ∆% T1 relaxation time.

KEY POINTS

• Gd-EOB-DTPA-enhanced MRI could give useful information on NAFLD. •HBP T 1 relaxation time measurement was useful for the evaluation of NAFLD. • HBP T 1 relaxation time measurement was as accurate as ∆%.

摘要

目的

本研究通过 T1 弛豫时间测量,评估钆塞酸二钠增强 MRI 在动物模型中非酒精性脂肪性肝病(NAFLD)诊断和分期中的价值。

方法

34 只兔子被分为对照组(n=10)和 NAFLD 组,后者又分为四组(n=6),分别给予高脂饮食 3 周。在肝胆期(HBP)前后进行双翻转角。计算肝实质 T1 弛豫时间和下降率(∆%)。根据脂肪变性、活动和纤维化的半定量评分的组织学发现作为参考标准。

结果

HBP 和 ∆% T1 弛豫时间测量在正常组和 NAFLD 组、非酒精性脂肪性肝炎(NASH)组和无 NASH 的 NAFLD 组(p=0.000-0.049)、纤维化组(p=0.000-0.019)之间有显著差异,但 F1 和 F2 之间无差异(p=0.834)。HBP 和 ∆% T1 弛豫时间的受试者工作特征曲线(AUC)下面积(AUCs)在选择 NASH 和活动评分≥2 时为 0.86-0.93,在选择 F≥1、2、3 时为 0.86-0.95。HBP 和 ∆% T1 弛豫时间在诊断性能方面无显著差异。

结论

钆塞酸二钠增强 MRI 的 HBP T1 弛豫时间测量对 SAF 评分评估 NAFLD 有用。HBP T1 弛豫时间测量与 ∆% T1 弛豫时间一样准确。

重点

• Gd-EOB-DTPA 增强 MRI 可提供有关 NAFLD 的有用信息。• HBP T1 弛豫时间测量对评估 NAFLD 有用。• HBP T1 弛豫时间测量与 ∆%一样准确。

相似文献

1
Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.钆塞酸二钠增强磁共振成像 T1 mapping 在非酒精性脂肪性肝病评估中的作用。
Eur Radiol. 2014 Apr;24(4):959-66. doi: 10.1007/s00330-014-3096-y. Epub 2014 Jan 26.
2
Non-contrast T1ρ dispersion versus Gd-EOB-DTPA-enhanced T1mapping for the risk stratification of non-alcoholic fatty liver disease in rabbit models.非对比T1ρ弥散与钆塞酸二钠增强T1成像用于兔模型中非酒精性脂肪性肝病风险分层的研究
Magn Reson Imaging. 2024 Apr;107:130-137. doi: 10.1016/j.mri.2024.01.013. Epub 2024 Jan 24.
3
Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.基于钆塞酸二钠增强 MRI 的非酒精性脂肪性肝病患者的组织学、影像学和人工智能特征的相关性:一项概念验证研究。
Eur Radiol. 2023 Nov;33(11):7729-7743. doi: 10.1007/s00330-023-09735-5. Epub 2023 Jun 26.
4
Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.评估 HBV 相关 HCC 患者的肝功能:钆塞酸二钠增强 MRI 的 T₁ mapping 与 DWI 的比较。
Eur Radiol. 2015 May;25(5):1392-8. doi: 10.1007/s00330-014-3542-x. Epub 2014 Dec 19.
5
Gd-EOB-DTPA-enhanced T1ρ imaging vs diffusion metrics for assessment liver inflammation and early stage fibrosis of nonalcoholic steatohepatitis in rabbits.钆塞酸二钠增强T1ρ成像与扩散指标用于评估兔非酒精性脂肪性肝炎的肝脏炎症和早期纤维化
Magn Reson Imaging. 2018 May;48:34-41. doi: 10.1016/j.mri.2017.12.017. Epub 2017 Dec 24.
6
T Mapping on Gd-EOB-DTPA-Enhanced MRI for the Prediction of Oxaliplatin-Induced Liver Injury in a Mouse Model.钆塞酸二钠增强MRI上的T映射用于预测小鼠模型中奥沙利铂诱导的肝损伤
J Magn Reson Imaging. 2021 Mar;53(3):896-902. doi: 10.1002/jmri.27377. Epub 2020 Sep 26.
7
Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.钆塞酸二钠增强MRI T1映射评估兔肝纤维化模型中的肝功能:10分钟和20分钟时获得的肝胆期图像比较
Radiol Med. 2017 Apr;122(4):239-247. doi: 10.1007/s11547-016-0719-1. Epub 2017 Jan 9.
8
Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla.在3.0特斯拉的Gd-EOB-DTPA增强磁共振成像(MRI)上使用T1映射评估肝段功能。
BMC Med Imaging. 2017 Mar 1;17(1):20. doi: 10.1186/s12880-017-0192-x.
9
Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits.钆塞酸二钠增强磁共振成像评估兔胆管结扎所致肝损伤的潜力
Hepatol Int. 2015 Apr;9(2):303-9. doi: 10.1007/s12072-014-9595-8. Epub 2014 Dec 6.
10
Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.钆塞酸二钠增强 MRI T1 mapping 技术 10 分钟和 20 分钟肝胆期图像用于临床肝功能评估的比较。
Abdom Radiol (NY). 2017 Sep;42(9):2272-2278. doi: 10.1007/s00261-017-1143-2.

引用本文的文献

1
Hepatocyte uptake ratio derived from T1 mapping for quantitative assessment of liver fibrosis.基于T1映射的肝细胞摄取率用于肝纤维化的定量评估。
Eur Radiol. 2025 Jul 30. doi: 10.1007/s00330-025-11842-4.
2
Efficient and Specific PDGFRβ-Targeting Dual-Mode T-T MRI Nanoprobe for Early Diagnosis of Non-Alcoholic Fatty Liver.用于非酒精性脂肪肝早期诊断的高效特异性靶向血小板衍生生长因子受体β的双模态T-T磁共振成像纳米探针
Adv Sci (Weinh). 2025 Jun;12(23):e2413788. doi: 10.1002/advs.202413788. Epub 2025 Mar 7.
3
Ability of dynamic gadoxetic acid-enhanced magnetic resonance imaging combined with water-specific T1 mapping to reflect inflammation in a rat model of early-stage nonalcoholic steatohepatitis.

本文引用的文献

1
Usefulness of Gd-EOB-DTPA-enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitis.钆塞酸二钠增强 MRI 在单纯性脂肪变性和非酒精性脂肪性肝炎评估中的作用。
J Magn Reson Imaging. 2013 May;37(5):1137-43. doi: 10.1002/jmri.23921. Epub 2012 Nov 21.
2
Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI.利用钆塞酸增强 MRI 的 T1 映射区分肝血管瘤与转移瘤。
Magn Reson Imaging. 2013 Jan;31(1):23-7. doi: 10.1016/j.mri.2012.06.026. Epub 2012 Aug 9.
3
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
动态钆塞酸二钠增强磁共振成像联合水特异性T1映射在早期非酒精性脂肪性肝炎大鼠模型中反映炎症的能力。
Quant Imaging Med Surg. 2024 Feb 1;14(2):1591-1601. doi: 10.21037/qims-23-482. Epub 2024 Jan 2.
4
Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based contrast agent.磁性-光学双模态成像监测低剂量纤连蛋白靶向钆基造影剂对胰腺导管腺癌的化疗疗效
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):1841-1855. doi: 10.1007/s00259-024-06617-w. Epub 2024 Feb 19.
5
Impact of fat on the apparent T1 value of the liver: assessment by water-only derived T1 mapping.肝脏表观 T1 值受脂肪影响的研究:水相衍生 T1 mapping 定量评估。
Eur Radiol. 2023 Oct;33(10):6844-6851. doi: 10.1007/s00330-023-10052-0. Epub 2023 Aug 8.
6
Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography.T1映射与非增强计算机断层扫描在肝组织特征分析中的比较
J Clin Med. 2022 May 19;11(10):2863. doi: 10.3390/jcm11102863.
7
Assessment of dynamic hepatic and renal imaging changes in COVID-19 survivors using T1 mapping and IVIM-DWI.使用 T1 mapping 和 IVIM-DWI 评估 COVID-19 幸存者的动态肝肾功能影像学变化。
Abdom Radiol (NY). 2022 May;47(5):1817-1827. doi: 10.1007/s00261-022-03471-y. Epub 2022 Mar 13.
8
Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease.基于常规和人工智能的影像学方法用于慢性肝病生物标志物的发现。
Hepatol Int. 2022 Jun;16(3):509-522. doi: 10.1007/s12072-022-10303-0. Epub 2022 Feb 9.
9
A Type I Collagen-Targeted MR Imaging Probe for Staging Fibrosis in Crohn's Disease.一种用于克罗恩病纤维化分期的靶向I型胶原的磁共振成像探针。
Front Mol Biosci. 2021 Nov 11;8:762355. doi: 10.3389/fmolb.2021.762355. eCollection 2021.
10
Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study.使用不同采集时间点的钆塞酸二钠增强 T1 mapping 评估慢性乙型肝炎患者的肝功能:一项可行性研究。
Radiol Med. 2021 Sep;126(9):1149-1158. doi: 10.1007/s11547-021-01382-4. Epub 2021 Jun 8.
病态肥胖患者肝脏病变的组织病理学算法和评分系统。
Hepatology. 2012 Nov;56(5):1751-9. doi: 10.1002/hep.25889.
4
Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.定量研究肝脏特异性对比剂 Gd-EOB-DTPA 和 Gd-BOPTA 在肝脏摄取方面的差异:一项初步研究。
Eur Radiol. 2012 Mar;22(3):642-53. doi: 10.1007/s00330-011-2302-4. Epub 2011 Oct 9.
5
Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression.钆塞酸二钠增强磁共振成像在大鼠非酒精性脂肪性肝炎和肝硬化中的信号特征:与转运体表达的相关性。
Eur Radiol. 2011 Dec;21(12):2542-50. doi: 10.1007/s00330-011-2228-x. Epub 2011 Aug 11.
6
Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.使用钆塞酸增强磁共振成像的肝增强率对肝纤维化进行分期:与天门冬氨酸氨基转移酶/血小板比值指数的比较。
Magn Reson Imaging. 2011 Oct;29(8):1047-52. doi: 10.1016/j.mri.2011.05.007. Epub 2011 Jul 19.
7
Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma.钆塞酸二钠增强 3.0T MR 成像:注射后 10 分钟和 20 分钟获得的肝细胞期图像的定量和定性比较,用于检测结直肠癌肝转移。
Eur Radiol. 2011 Nov;21(11):2336-43. doi: 10.1007/s00330-011-2197-0. Epub 2011 Jul 12.
8
Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.钆塞酸二钠增强磁共振成像定量评估肝功能。
Radiology. 2011 Sep;260(3):727-33. doi: 10.1148/radiol.11100586. Epub 2011 Jun 28.
9
Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging.钆塞酸二乙三胺五乙酸增强磁共振成像 T2* 映射法评估肝功能。
Eur J Radiol. 2012 Jul;81(7):1460-4. doi: 10.1016/j.ejrad.2011.03.073. Epub 2011 Apr 21.
10
Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging.利用 Gd-EOB-DTPA 增强磁共振成像的 T1 映射评估肝功能。
Invest Radiol. 2011 Apr;46(4):277-83. doi: 10.1097/RLI.0b013e318200f67d.